26 May 2013
Keywords: solvay, launches, r3i, non-profit, organization, belgian, drugs
Article | 17 November 2008
Belgian drugs and chemicals firm Solvay Pharmaceuticals has provided seed funding for the Residual Risk Reduction initiative (R3i), a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.